Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Neoadjuvant treatment of locally advanced esophageal and junctional cancer: the evidence-base, current key questions and clinical trials.

Donohoe CL, Reynolds JV.

J Thorac Dis. 2017 Jul;9(Suppl 8):S697-S704. doi: 10.21037/jtd.2017.03.159. Review.

2.

ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS).

Reynolds JV, Preston SR, O'Neill B, Baeksgaard L, Griffin SM, Mariette C, Cuffe S, Cunningham M, Crosby T, Parker I, Hofland K, Hanna G, Svendsen LB, Donohoe CL, Muldoon C, O'Toole D, Johnson C, Ravi N, Jones G, Corkhill AK, Illsley M, Mellor J, Lee K, Dib M, Marchesin V, Cunnane M, Scott K, Lawner P, Warren S, O'Reilly S, O'Dowd G, Leonard G, Hennessy B, Dermott RM.

BMC Cancer. 2017 Jun 3;17(1):401. doi: 10.1186/s12885-017-3386-2.

3.

Cancer of the esophagus and esophagogastric junction: an 8th edition staging primer.

Donohoe CL, Phillips AW.

J Thorac Dis. 2017 Mar;9(3):E282-E284. doi: 10.21037/jtd.2017.03.39. No abstract available.

4.

The role of obesity in gastrointestinal cancer: evidence and opinion.

Donohoe CL, O'Farrell NJ, Doyle SL, Reynolds JV.

Therap Adv Gastroenterol. 2014 Jan;7(1):38-50. doi: 10.1177/1756283X13501786. Review.

5.

Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis.

Allott EH, Morine MJ, Lysaght J, McGarrigle SA, Donohoe CL, Reynolds JV, Roche HM, Pidgeon GP.

Clin Transl Gastroenterol. 2012 Apr 19;3:e12. doi: 10.1038/ctg.2012.5.

6.

Cancer cachexia: mechanisms and clinical implications.

Donohoe CL, Ryan AM, Reynolds JV.

Gastroenterol Res Pract. 2011;2011:601434. doi: 10.1155/2011/601434. Epub 2011 Jun 13.

7.

Visceral adiposity, insulin resistance and cancer risk.

Donohoe CL, Doyle SL, Reynolds JV.

Diabetol Metab Syndr. 2011 Jun 22;3:12. doi: 10.1186/1758-5996-3-12.

Supplemental Content

Loading ...
Support Center